Influence of increased body mass index on drug toxicity in patients with acute promyelocytic leukemia

Access through your institution Buy or subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this

journal Receive 12 print issues and online access $259.00 per year only $21.58 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now

Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer

support AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Service d'Hematologie, Hôpital Edouard Herriot, 69437, Lyon, Cedex 03, Lyon, France X Thomas, D Fiere & ✠E Archimbaud Authors *

X Thomas View author publications You can also search for this author inPubMed Google Scholar * D Fiere View author publications You can also search for this author inPubMed Google Scholar

* ✠E Archimbaud View author publications You can also search for this author inPubMed Google Scholar RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE

Thomas, X., Fiere, D. & Archimbaud, ✠. Influence of increased body mass index on drug toxicity in patients with acute promyelocytic leukemia. _Leukemia_ 12, 1503–1505 (1998).

https://doi.org/10.1038/sj.leu.2401126 Download citation * Received: 20 April 1998 * Accepted: 15 May 1998 * Published: 02 September 1998 * Issue Date: 01 September 1998 * DOI:

https://doi.org/10.1038/sj.leu.2401126 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not

currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative